NASDAQ:BGLC BioNexus Gene Lab (BGLC) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free BGLC Stock Alerts $0.59 +0.00 (+0.15%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Today's Range$0.58▼$0.6250-Day Range$0.56▼$1.0752-Week Range$0.31▼$17.88Volume37,900 shsAverage Volume1.22 million shsMarket Capitalization$10.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get BioNexus Gene Lab alerts: Email Address Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic About BioNexus Gene Lab Stock (NASDAQ:BGLC)BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Read More BGLC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BGLC Stock News HeadlinesApril 26, 2024 | americanbankingnews.comAnalyzing Elekta AB (publ) (OTCMKTS:EKTAY) & BioNexus Gene Lab (NASDAQ:BGLC)April 23, 2024 | americanbankingnews.comAnalyzing BioNexus Gene Lab (NASDAQ:BGLC) & Renalytix (NASDAQ:RNLX)April 29, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…April 19, 2024 | msn.comWhy Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionApril 19, 2024 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?April 18, 2024 | marketwatch.comBioNexus Gene Lab Invests in AI Healthcare CompanyApril 18, 2024 | globenewswire.comBioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareFebruary 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Short Interest ReportApril 29, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…February 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Analyst Ratings, Price Targets, PredictionsFebruary 14, 2024 | finance.yahoo.comCompanies Like BioNexus Gene Lab (NASDAQ:BGLC) Can Afford To Invest In GrowthDecember 20, 2023 | nasdaq.comBioNexus Gene Lab Corp Common stock (BGLC)November 22, 2023 | seekingalpha.comBGLC BioNexus Gene Lab Corp.October 16, 2023 | sg.finance.yahoo.comBioNexus Gene Lab Corp. (BGLC)August 23, 2023 | markets.businessinsider.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 33% Today?July 28, 2023 | investing.comBioNexus Gene Lab Corp (BGLC)July 24, 2023 | seekingalpha.comIPO Roundup: Surf Air Mobility, Opti-Harvest and moreJuly 24, 2023 | finanznachrichten.deBIONEXUS GENE LAB CORPJuly 24, 2023 | finance.yahoo.comBioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketJuly 21, 2023 | morningstar.comBioNexus Gene Lab Corp Ordinary SharesJuly 21, 2023 | msn.comInvestors Look to Close Week on Positive Note as US Futures See Mixed Performance Premarket FridayJuly 21, 2023 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 64% Today?July 20, 2023 | finance.yahoo.comBioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketJuly 19, 2023 | finance.yahoo.comBGLC - BioNexus Gene Lab Corp.July 19, 2023 | wsj.comBioNexus Gene Lab Corp.See More Headlines Receive BGLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/28/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:BGLC CUSIPN/A CIK1737523 Webwww.bionexusgenelab.com Phone60-1-2212-6512FaxN/AEmployees27Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,630,000.00 Net Margins-26.90% Pretax Margin-26.69% Return on Equity-32.99% Return on Assets-26.99% Debt Debt-to-Equity RatioN/A Current Ratio4.93 Quick Ratio4.24 Sales & Book Value Annual Sales$9.77 million Price / Sales1.08 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book1.08Miscellaneous Outstanding Shares17,790,000Free Float16,576,000Market Cap$10.56 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Su-Leng Tan (Age 40)CEO, Acting CFO, Secretary & Director Comp: $16kMr. Kwan Wah ChanMarketing ManagerMr. Too Kam ThamManaging DirectorKey CompetitorsInnoNASDAQ:INHDForemost Lithium Resource & TechnologyNASDAQ:FMSTAustin GoldNYSE:AUSTChina Natural ResourcesNASDAQ:CHNRGolden MineralsNYSE:AUMNView All Competitors BGLC Stock Analysis - Frequently Asked Questions How have BGLC shares performed in 2024? BioNexus Gene Lab's stock was trading at $0.53 at the beginning of 2024. Since then, BGLC stock has increased by 12.0% and is now trading at $0.5935. View the best growth stocks for 2024 here. Are investors shorting BioNexus Gene Lab? BioNexus Gene Lab saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 99,700 shares, an increase of 129.7% from the March 31st total of 43,400 shares. Based on an average daily volume of 1,510,000 shares, the short-interest ratio is presently 0.1 days. Approximately 1.4% of the company's stock are short sold. View BioNexus Gene Lab's Short Interest. When is BioNexus Gene Lab's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our BGLC earnings forecast. When did BioNexus Gene Lab IPO? BioNexus Gene Lab (BGLC) raised $5 million in an initial public offering on Thursday, July 20th 2023. The company issued 1,300,000 shares at $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO. How do I buy shares of BioNexus Gene Lab? Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BGLC) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
